Survey of COVID-19 Infection | NCT05706064

Studies
Survey of COVID-19 Infection

NCT05706064

Sponsor

Xijing Hospital

Status

Completed

Last Update Posted

Jan 24, 2024Actual

Enrollment

200,000Actual

Phase

Not provided

Conditions

COVID-19
Infections

Interventions

Not provided

Countries

China

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jan 2024

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Dec 28, 2022Actual

Primary Completion Date

Apr 30, 2023Actual

Completion Date

Jun 30, 2023Actual

First Submitted Date

Jan 29, 2023

First Submission Date that Met QC Criteria

Jan 29, 2023

First Posted Date

Jan 31, 2023Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jan 22, 2024

Last Update Posted Date

Jan 24, 2024Actual

Sponsor/Collaborators Module

Responsible Party, by Official Title

LingTao, Professor in Cardiology, Director of the department of Cardiology, Xijing HospitalPrincipal Investigator

Lead Sponsor

Xijing HospitalOTHER

Collaborators

Not provided

Oversight Module

Has Data Monitoring Committee (DMC)

Not provided

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

Using online questionnaires, we will obtain data regarding COVID-19 infection and treatment, including incidence rate, hospitalization rate, severity of the infection, medications, mortality rate, etc, in both hospital and communities after the change of disease control policy in China.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Yes

Target Follow-Up Duration

1 Day

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

200,000Actual

Label	Type	Description	Intervention Names
COVID-19 Infection

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
All-cause mortality	Quickly obtain the all-cause mortality in patients with COVID-19	6 months

Secondary Outcomes

Measure	Description	Time Frame
Incidence rate of COVID-19 infection	Incidence rate of COVID-19 infection	6 months
Medication for COVID-19 treatment	Any medication for COVID-19 treatment

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Exclusion Criteria:

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

Not provided

Maximum Age

Not provided

Standard Ages

ChildAdultOlder Adult

Study Population

All population from hospital and community

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Ling Tao, MD, Ph.D.	Xijing Hospital	Study Chair
Chao Gao, MD, Ph.D.	Xijing Hospital	Study Chair

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Ling Tao		Xi'an	Shannxi	710032	China

IPD Sharing Statement Module

Plan to Share IPD

Description

Not provided

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided

Condition Browse Module

MeSH Terms

ID	Term
D000086382	COVID-19
D007239	Infections

Ancestor Terms

ID	Term
D011024	Pneumonia, Viral
D011014	Pneumonia
D012141	Respiratory Tract Infections
D014777	Virus Diseases

Browse Leaves

Not provided

Browse Branches

Not provided